Reevaluation of categorial outcomes using common clinically relevant improvement thresholds following bilateral L2 medial branch restorative neurostimulation versus sham

医学 神经刺激 临床终点 麻醉 随机对照试验 最小临床重要差异 临床试验 生活质量(医疗保健) 物理疗法 物理医学与康复 外科 神经调节
作者
Matthew W. Smuck,Dylan Lukes,Byron J. Schneider,David J. “D.J.” Kennedy,Allen S. Chen,Zachary L. McCormick
出处
期刊:The Spine Journal [Elsevier BV]
卷期号:26 (5): 996-1005 被引量:2
标识
DOI:10.1016/j.spinee.2025.12.002
摘要

BACKGROUND CONTEXT: When chronic low back pain (cLBP) persists after conservative management, there are limited treatment options. Increasingly, researchers and clinicians are defining distinct phenotypes within the cLBP population to develop and provide more targeted and effective interventions. One such phenotype involves people with mechanical low back pain and impaired motor control, identified by physical exam or MRI evidence of multifidus dysfunction. An implantable neurostimulation device that delivers an electrical stimulation to the L2 medial branch has been recently FDA-approved, with initially encouraging preliminary results. The pivotal trial demonstrated statistically-significant benefits over sham treatment in all secondary outcomes but not the primary outcome at the 120-day primary endpoint. However, recently published 1- and 5-year studies have shown better outcomes compared to optimal medical management. PURPOSE: It was our purpose to expand the comparison of clinical outcomes between this neurostimulation treatment and sham by reevaluating the data from the aforementioned pivotal trial using common clinically-relevant thresholds of treatment success that were not included in the pivotal trial's uncommon composite definition of treatment success or in its analysis of secondary outcomes for Oswestry Disability Index (ODI) and EQ-5D that compared mean improvements instead of categorical responder rates. STUDY DESIGN/SETTING: Posthoc reanalysis of previously published data from a prospective, randomized, double-blind, multicenter sham-controlled clinical trial. PATIENT SAMPLE: From 26 centers, 204 participants age 46.53±9.38 years (range 22-71) and 53.9% (110/204) female were recruited with mechanical cLBP despite physical therapy and medical management, and a positive prone instability test on physical exam. OUTCOME MEASURES: Participants completed several patient-reported outcomes at baseline and at the primary endpoint of 120 days following activation of the implanted stimulator or sham, including: visual analog scale, ODI, EQ-5D, and subject global impression of change. METHODS: Using a complete-case analysis, we compared differences between the neurostimulation treatment group and the sham-control group. Demographics are expressed using descriptive statistics. Patient-reported outcomes are compared between groups with a categorical analysis, setting responder thresholds at commonly used benchmarks and established minimum clinically important change (MCIC) thresholds. Statistical significance is determined by a 2-sided p-value from Fisher's exact test with significance set at p<.05. Potential conflicts of interest directly related to this manuscript include research funding to support MS (level e) and DL (level b). The sponsor funded the original sham-controlled trial and funded this reanalysis but had no role in the reanalysis design, its prespecified analysis plan, its statistical analysis, or manuscript preparation. The authors had full access to the data and final responsibility for the decision to submit. RESULTS: A total of 3 patients (2 active, 1 sham) were lost to follow-up, leaving 201 participants in the complete-case analysis. From baseline to the 120-day primary endpoint, statistically-significant differences were observed in favor of active treatment at the MCIC thresholds of ODI: ≥15-point improvement (59% vs 40.6%; p=.0111) and ≥30% improvement (65.0% vs 47.5%; p=.0156); the MCIC of EQ-5D: ≥0.15 improvement (57.0% vs 36.0%; p=.0045); and subject global impression of change of "better" or more (54.0% vs 33.7%; p=.0045). Pain outcomes were mixed; categorical responder rates did not differ significantly (MCIC ≥2-point visual analog scale improvement and ≥50% improvement), although mean changes favored active treatment (-3.3±2.7 vs -2.4±2.9; p=.0209). CONCLUSIONS: Comparing bilateral L2 medial branch restorative neurostimulation to sham at the primary endpoint of 120 days, employing common clinically-relevant thresholds for treatment success, this sponsor-funded reanalysis of the sham-controlled pivotal trial demonstrated statistically-significant and clinically meaningful benefits in favor of treatment in disability, quality of life, and patient satisfaction, while changes in pain bore mixed results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大模型的应助被刘宇翔采纳,获得10
刚刚
hhy发布了新的文献求助10
刚刚
刚刚
EarendilK完成签到,获得积分10
1秒前
Yola发布了新的文献求助10
1秒前
没名字完成签到 ,获得积分10
1秒前
1秒前
liang完成签到,获得积分10
1秒前
机智成危完成签到,获得积分10
2秒前
田様的应助被典雅翅膀采纳,获得10
3秒前
自然如曼完成签到 ,获得积分10
3秒前
3秒前
陈泓宇发布了新的文献求助10
3秒前
Akim的应助被water1201采纳,获得10
3秒前
3秒前
wwkxqly完成签到,获得积分10
4秒前
whc发布了新的文献求助10
4秒前
在水一方的应助被强风吹拂采纳,获得20
4秒前
徐文欣完成签到 ,获得积分10
5秒前
6秒前
qian发布了新的文献求助10
6秒前
DKO253完成签到,获得积分10
6秒前
6秒前
椒盐天蛾完成签到 ,获得积分10
6秒前
顾矜的应助被cbx采纳,获得10
7秒前
7秒前
Hase发布了新的文献求助30
7秒前
7秒前
7秒前
傻死一只橙子完成签到,获得积分10
8秒前
yimuyi发布了新的文献求助10
8秒前
qqqqq完成签到,获得积分10
8秒前
9秒前
江江发布了新的文献求助20
9秒前
9秒前
ada发布了新的文献求助10
9秒前
9秒前
9秒前
AAA卫生院保洁杨姐完成签到 ,获得积分10
9秒前
好好活着的应助被孤独梦曼采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160632
求助须知:如何正确求助?哪些是违规求助? 9555512
关于积分的说明 21728801
捐赠科研通 7750444
什么是DOI,文献DOI怎么找? 3427429
关于科研通互助平台的介绍 2552456
邀请新用户注册赠送积分活动 2471817